Inventor
NIYIKIZA CLET
US39 patents
⚠️ This page may combine multiple inventors who share the name “NIYIKIZA CLET”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
L E A F HOLDINGS GROUP LLC
29 patentsUS11344628B2May 31, 2022
Alpha polyglutamated antifolates and uses thereof
L E A F HOLDINGS GROUP LLC32 citations97
US11701432B2Jul 18, 2023
Polyglutamated antifolates and uses thereof
L E A F HOLDINGS GROUP LLC17 citations94
US11534498B2Dec 27, 2022
Polyglutamated antifolates and uses thereof
L E A F HOLDINGS GROUP LLC29 citations94
US12076402B2Sep 3, 2024
Alpha polyglutamated antifolates and uses thereof
L E A F HOLDINGS GROUP LLC6 citations85
US12048766B2Jul 30, 2024
Gamma polyglutamated tetrahydrofolates and uses thereof
L E A F HOLDINGS GROUP LLC14 citations85
US12048767B2Jul 30, 2024
Gamma polyglutamated pralatrexate and uses thereof
L E A F HOLDINGS GROUP LLC10 citations85
US11779584B2Oct 10, 2023
Alpha polyglutamated pemetrexed and uses thereof
L E A F HOLDINGS GROUP LLC13 citations85
US11771700B2Oct 3, 2023
Gamma polyglutamated lometrexol and uses thereof
L E A F HOLDINGS GROUP LLC11 citations85
US11730738B2Aug 22, 2023
Alpha polyglutamated pralatrexate and uses thereof
L E A F HOLDINGS GROUP LLC10 citations85
US12128046B2Oct 29, 2024
Alpha polyglutamated methotrexate and uses thereof
L E A F HOLDINGS GROUP LLC4 citations74
US12178882B2Dec 31, 2024
Alpha polyglutamated pemetrexed and uses thereof
L E A F HOLDINGS GROUP LLC2 citations73
US12178883B2Dec 31, 2024
Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereof
L E A F HOLDINGS GROUP LLC2 citations73
US12433893B2Oct 7, 2025
Alpha polyglutamated pemetrexed and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12350271B2Jul 8, 2025
Gamma polyglutamated aminopterin and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12336994B2Jun 24, 2025
Alpha polyglutamated tetrahydrofolates and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12310966B2May 27, 2025
Alpha polyglutamated aminopterin and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12296022B2May 13, 2025
D glutamate polyglutamated antifolates and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12290518B2May 6, 2025
Gamma polyglutamated methotrexate and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12246015B2Mar 11, 2025
Alpha polyglutamated raltitrexed and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12246018B2Mar 11, 2025
Gamma polyglutamated pemetrexed and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12246019B2Mar 11, 2025
Alpha polyglutamated lometrexol and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12239734B2Mar 4, 2025
Gamma polyglutamated raltitrexed and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12220431B2Feb 11, 2025
Gamma polyglutamated antifolates and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12213981B2Feb 4, 2025
Alpha polyglutamated pralatrexate and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12201695B2Jan 21, 2025
Polyglutamated pemetrexed and uses thereof
L E A F HOLDINGS GROUP LLC0 citations62
US12458597B2Nov 4, 2025
Carotenoid compositions and uses thereof
L E A F HOLDINGS GROUP LLC1 citations60
US12115256B2Oct 15, 2024
Targeted liposomal gemcitabine and methods thereof
L E A F HOLDINGS GROUP LLC0 citations59
US10940112B2Mar 9, 2021
Targeted liposomal gemcitabine compositions and methods thereof
L E A F HOLDINGS GROUP LLC0 citations59
US12161757B2Dec 10, 2024
Platinum complexes and uses thereof
L E A F HOLDINGS GROUP LLC0 citations53
IPSEN BIOPHARM LTD
4 patentsUS9717724B2Aug 1, 2017
Methods for treating pancreatic cancer using combination therapies
IPSEN BIOPHARM LTD14 citations91
US10980795B2Apr 20, 2021
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
IPSEN BIOPHARM LTD8 citations83
US11369597B2Jun 28, 2022
Methods for treating pancreatic cancer using combination therapies
IPSEN BIOPHARM LTD4 citations72
US12364691B2Jul 22, 2025
Methods for treating pancreatic cancer using combination therapies
IPSEN BIOPHARM LTD0 citations61
MERRIMACK PHARMACEUTICALS INC
4 patentsUS9492442B2Nov 15, 2016
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
MERRIMACK PHARMACEUTICALS INC19 citations91
US9452162B2Sep 27, 2016
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
MERRIMACK PHARMACEUTICALS INC12 citations91
US9364473B2Jun 14, 2016
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
MERRIMACK PHARMACEUTICALS INC12 citations91
US9339497B2May 17, 2016
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
MERRIMACK PHARMACEUTICALS INC17 citations91